Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
Status:
Withdrawn
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
PURPOSE: To evaluate patient adherence to cream versus tablet based local estrogen therapy by
randomizing treatment modalities to determine differences in adherence to either form.
HYPOTHESIS: There is no difference in adherence to cream versus tablet based local estrogen
therapy when prescribed as a 6 week course of postoperative therapy after female pelvic
reconstructive surgery.